Rayonier, L.P.
Archive
Press releases, November 2026
411 releases
3d Systems Corp
3D Systems Reports Third Quarter 2026 Financial Results
Veracyte, Inc.
Veracyte Announces Third Quarter 2026 Financial Results
Grew total revenue to $151.8 million and testing revenue to $146.4 million, representing 15% year-over-year growth
Sera Prognostics, Inc.
PreTRM® test volume increases 54% sequentially and approximately five-fold from 1Q26
Ordering healthcare providers increase 34% sequentially and approximately three-fold from 1Q26
Unlikely Collaborators
Unlikely Collaborators Awards $7.2 Million to Expand Perception Box Work at Nonprofits Nationwide
First national RFP supports 26 new nonprofit partners and continues funding for 26 organizations bringing Perception Box awareness into communities…
Lemaitre Vascular Inc
LeMaitre Q3 2026 Financial Results
Youlife Group Inc.
Youlife Group Inc. Announces Initial US$3.0 Million Convertible Note Registered Direct Offering and Potential Additional Investments of Up to US$9.0 Million
Youlife Group Inc. ("Youlife" or the "Company") (NASDAQ: YOUL), a leading blue-collar lifetime service provider in China, today announced that it has…
Purple Innovation, LLC
Purple Innovation Reports Third Quarter 2026 Results
Positive Operating Cash Flow for the Third Consecutive Quarter Preparing for Major Mattress Portfolio Refresh to Strengthen Performance in 2027 LEHI,…
MGIC Investment Corporation
MGIC Investment Corporation Reports Third Quarter 2026 Results
Third Quarter 2026 Net Income of $175.0 million or $0.85 per Diluted Share Third Quarter 2026 Adjusted Net Operating Income (Non-GAAP) of $174.7…
Laza Medical, Inc.
Laza Medical Raises Up to $160 Million in Series B Financing Led by GE HealthCare to Advance Intelligent Imaging for Transforming the Cath Lab
Company's first-of-a-kind intelligent imaging system aims to expand patient access, streamline high-quality cardiac care, and establish the…
Dianthus Therapeutics, Inc. /DE/
Advancing a neuromuscular franchise with claseprubart, a highly potent, investigational classical pathway inhibitor, with best-in-disease potential across generalized Myasthenia Gravis (gMG), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), and Multifocal Motor Neuropathy (MMN)
Phase 3 EMERGE registrational trial of claseprubart in gMG evaluating 300mg/2mL Q2W and 300mg/2mL Q4W on track, with top-line results expected in…
Chime Financial, Inc.
Chime Reports Third Quarter 2026 Financial Results
Revenue grows 32% year over year to $718 million
Snap Inc
Snap Inc. Announces Third Quarter 2026 Financial Results
Third quarter revenue increased 14% year-over-year to $1,722 million
Cboe Global Markets, Inc.
Cboe Global Markets Reports Trading Volume for October 2026
Cboe Global Markets, Inc. (Cboe: CBOE), a leading global markets operator and pioneer in equity and index derivatives, today reported October trading…
Outset Medical, Inc.
Outset Medical Reports Third Quarter 2026 Results
Granite Point Mortgage Trust Inc.
Granite Point Mortgage Trust Inc. Reports
Third Quarter 2026 Financial Results